Top Tweets for #IMMONC
Article of the day, September 10th, suggested by the @ImmoncInstitute
https://t.co/nC30DKD8UI
#CancerΒ #IMMONC #OncologyResearch Β #OncoDailyΒ #OncologyΒ #UGCI #MedEd #MedNews #MedX #Medicine #Health
Immune Oncology Research Institute at the @ASCO 2024 Annual Meeting
@ImmoncInstitute
https://t.co/YezP25rWtN
#IMMONC #ASCO2024 #Cancer #Oncology #OncoDaily #CancerPrevention
Clinical Trial Update by @ImmoncInstitute
@JHoveyan @ruzanna_papyan @pcbdca
https://t.co/1rNT3JTUSa
#Cancer #OncologyResearch #OncoDaily #Oncology #PediatricCancer #ClinicalTrial #IMMONC #BloodCancer
Happy to share that IMMONC received regulatory approval to conduct a trial of BAL+BOT among patients with metastatic non-small cell lung cancer - Karen Bedirian
@ImmoncInstitute @Agenus_Bio
#Balstilimab #Botensilimab #Cancer #IMMONC #OncoDaily #Oncology
https://t.co/W0nhAUUEHn
This is just the beginning, and I am sure soon we will have more to present. Armenia will become a regional hub for cancer research and treatment!
https://t.co/2Aj9Z6ehXv
#cancerresearch #cancertreatment #oncodaily #oncology #IMMONC #Armenia
https://t.co/ij74Wb4wa1
In 16 months, we have registered more cancer clinical trials in Armenia, than throughout all the years before that β Gevorg Tamamyan
#Armenia #cancerresearch #clinicaltrials
Great comprehensive presentation by super @RebeccaDSing at #ESMOasia22 on #immunotherapy in early triple-negative #BreastCancer: important citation for the recent review by @ElisaAgostinett & the great algorithm for #TNBC treatment by @hoperugo
@OncoAlert @myESMO #bcsm #ImmOnc
Nice cartoon from a useful #tweetorial by @curijoey on role of #immunotherapy in advanced triple-negative #BreastCancer
@UmbertoMalapel1 #TNBC #ImmOnc #IO
The emergence of cancer immunotherapy, including immune checkpoint inhibitors (ICIs), is revolutionizing the way we treat mTNBC. In mTNBC, first-line ICI + chemotherapy combinations improved survival outcomes in patients with PD-L1+ (programmed death ligand-1-positive) disease
Great talk by @RebeccaDSing at the #ASCO22 poster discussion: still many questions remaining for a proper implementation of #immunotherapy in early triple-negative #BreastCancer
@OncoAlert #IO #ImmOnc
Early #BreastCancer Oral Abstract session at #ASCO21: data from #GeparNUEVO trial showing improved survival outcomes with the addition of #durvalumab to neoadjuvant #anthracycline- and #taxane-based #chemotherapy in #TNBC
@OncoAlert #bcsm #ImmOnc @GBG_Forschung
Very important news for #TripleNegative early #BreastCancer patients: #KEYNOTE-522 trial (neoadjuvant #chemotherapy +/- #pembrolizumab) met its 2nd primary endpoint of #EFS, but important to see the absolute magnitude of benefit
@OncoAlert #bcsm #ImmOnc
https://t.co/yBbmQc8uTr
Very nice discussion at #SABCS20 General Session 3 on #immunotherapy in #BreastCancer with the potential differences between the early vs. advanced settings (including the role of #PDL1): many questions remain to be answered !
@OncoAlert @SABCSSanAntonio #bcsm #ImmOnc
General Session 3 at #SABCS20: @EMittendorfMD presenting patient-reported outcomes #PRO analysis from #IMpassion031 trial of neoadjuvant #atezolizumab added to #chemotherapy in patients with early #TripleNegative #BreastCancer #TNBC
@OncoAlert @SABCSSanAntonio #bcsm #ImmOnc
General Session 3 at #SABCS20: more data presented by the great @hoperugo on the #KEYNOTE355 trial showing the benefit of adding #pembrolizumab to #chemotherapy as first-line therapy in patients with #TripleNegative #BreastCancer
@OncoAlert @SABCSSanAntonio #bcsm #ImmOnc #TNBC
Combination of #chemotherapy and #pembrolizumab now approved by @US_FDA as first-line therapy in advanced #TripleNegative #PDL1-positive #BreastCancer: and now which #ICI and which #chemotherapy to choose ?
@OncoAlert #TNBC #bcsm #ImmOnc #FDA
https://t.co/8xHQCpD7Sq
Other important upcoming data in #BreastCancer: addition of #atezolizumab to neoadjuvant #anthracycline- and #taxane-based #chemotherapy improves pCR rates regardless of #PDL1 status in #TripleNegative early disease
#OncoAlert #bcsm #immunotherapy #ImmOnc https://t.co/Fu0DuBMXo4
#OncoAlert & #BreastCancer & #bcsm
Just published in @JAMAOnc an updated review on the current landscape of #immunotherapy in this disease: combination therapy strategies will be the way forward #io #immonc
https://t.co/3VPU6Q4OLf
#Hotoffthepress This review is a "must read" for #oncology fellows, shoot, for anyone else taking care of a #cancer patient today on #Immunotherapy @NEJM https://t.co/g6dYB3c4zj #immonc
Mellman: Despite remarkable data, #Immunotherapy is of limited benefit TODAY 4 MOST #cancer pts #immonc #SITC2016
Last Seen Hashtags on Sotwe
ChemicalfreeVegetables
Seen from United States
Ψ³Ψ§ΩΨ¨_Ψ―Ψ¨Ω
Seen from Singapore
GemsOfRadhakka
Seen from United States
YOURSMILEOURPRIDE
Seen from United States
ΰΈΰΉΰΈ²ΰΈΰΈ΄ΰΈΰΈΰΈΰΈΰΉΰΈΰΉΰΈ
Seen from Thailand
joi
Seen from Japan
momson() +filter:native_video
Seen from Indonesia
ΰΈ£ΰΈ±ΰΈΰΈΰΈ₯ΰΈΰΉΰΈͺΰΈ΅ΰΈ’ΰΈ§ΰΉΰΈΰΈ΄ΰΈΰΈΰΈ₯ΰΉΰΈΰΈ
Seen from Thailand
Momson
Seen from Brazil
wata()
Seen from Turkey
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241M followers
Barack Obama
@barackobama
119.2M followers
Cristiano Ronaldo
@cristiano
112.1M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.3M followers
KATY PERRY
@katyperry
88.5M followers
Taylor Swift
@taylorswift13
82.4M followers
Lady Gaga
@ladygaga
73.9M followers
Virat Kohli
@imvkohli
71.2M followers
Kim Kardashian
@kimkardashian
70.2M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.4M followers
Neymar Jr
@neymarjr
64.1M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.6M followers
X
@x
60.8M followers